Abgenix's Acquisition

Abgenix was acquired by Amgen on April 01, 2006.

Abgenix aims to deliver fully human monoclonal antibodies for a range of disease targets, several of which are currently in clinical trials. The company leverages its XenoMouse technology platform to …

Articles about Abgenix's Acquisition: